Inactive Instrument
Sector Signal Genetics Inc Nasdaq
Stocks
US8266401046
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-16 | Sling Therapeutics raises $123 million to advance thyroid eye disease drug | RE |
| 08-31 | Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | -0.30% | +6.32% | +32.63% | +84.62% | +58.96% | +94.17% | +11.49% | - | 71.53B | |
| -0.19% | +1.32% | -3.29% | +4.36% | +18.14% | +37.20% | +81.33% | +226.32% | +5,434.64% | 60.12B | |
| -1.51% | +2.39% | -0.24% | +5.39% | +6.95% | +9.10% | +36.79% | -18.02% | +209.91% | 48.85B | |
| +1.10% | +1.17% | +3.75% | +40.25% | +20.22% | +42.67% | +39.77% | +13.13% | +234.31% | 44.28B | |
| +2.02% | +9.13% | +1.26% | +11.14% | +161.33% | +345.72% | +695.38% | +656.63% | - | 43.83B | |
| +2.28% | +2.23% | +3.77% | +30.94% | +22.82% | +9.52% | +109.04% | +2.79% | +1,111.07% | 41.53B | |
| -0.67% | -0.45% | -6.82% | -0.84% | +3.09% | +4.47% | +46.37% | -17.19% | +134.15% | 30.13B | |
| +4.77% | +6.46% | +10.66% | +58.87% | +78.28% | +41.54% | +22.78% | -55.45% | - | 27.98B | |
| +0.17% | -2.40% | -5.19% | +8.33% | -33.64% | -19.80% | +355.26% | +319.39% | +695.45% | 25.25B | |
| -0.18% | -0.23% | -3.33% | +5.57% | +3.18% | -0.40% | -12.88% | -64.02% | - | 24.76B | |
| +1.12% | +2.23% | +10.41% | +30.53% | +15.59% | +21.56% | -4.13% | -16.59% | +107.35% | 20.99B | |
| +0.47% | +1.05% | +4.99% | +17.76% | +11.04% | +21.29% | +157.10% | +229.47% | +1,988.51% | 17.36B | |
| +1.67% | +4.74% | -21.36% | +6.12% | +186.76% | +163.24% | +345.14% | +1,419.98% | +651.59% | 15.54B | |
| -1.57% | -1.52% | +3.39% | +9.39% | +20.19% | +21.40% | +43.29% | -32.33% | +85.48% | 14.99B | |
| +0.64% | +2.70% | -12.88% | -14.09% | - | - | - | - | - | 14.98B | |
| +2.22% | +10.21% | +33.88% | +45.71% | +42.95% | +4.58% | - | - | - | 14.9B | |
| +3.90% | +6.56% | +10.63% | +11.10% | +37.92% | +46.37% | +172.05% | +185.95% | +372.63% | 14.53B | |
| +2.96% | -0.65% | -5.34% | +11.80% | +24.17% | -1.74% | +535.77% | - | - | 14.41B | |
| +0.86% | +7.27% | +3.21% | +31.18% | +49.14% | +90.14% | +53.83% | -27.91% | +256.97% | 14.13B | |
| Average | +1.29% | +0.41% | +1.78% | +18.22% | +41.82% | +49.77% | +163.00% | +177.10% | +940.17% | 29.48B | |
| Weighted average by Cap. | +1.36% | +0.51% | +1.71% | +19.30% | +43.78% | +56.49% | +151.85% | +145.33% | +1,358.48% |
- Stock Market
- Stocks
- VRDN Stock
- Stock
- Sector Signal Genetics Inc
Select your edition
All financial news and data tailored to specific country editions
